{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 165,
  "pageCount": 239,
  "prevPage": 164,
  "nextPage": 166,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Highlights specific exclusion criteria (BMI, pain location, SSDI, worker's comp) using red boxes to support the 'cherry-picking' argument.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "numbered_list",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/165",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-165",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The SENZA-PDN study's exclusion criteria are sweeping and aggressive, illustrating the cherry-picking and absurdity KOL's pointed out.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b344-7c7d18bf8334",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.9,
        "x": 0.06,
        "y": 0.32
      },
      "kind": "list",
      "text": "1. Have a diagnosis of a lower limb mononeuropathy... 2. Have a BMI >= 40. 3. Currently prescribed a daily opioid dosage > 120 mg morphine equivalents. 4. Have a medical condition or pain in other area(s)... 5-19... 20. Be a recipient of Social Security Disability Insurance (SSDI). 21. Have a pending or approved worker's compensation claim. 22. Have evidence of an active disruptive psychological...",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9ef055a-14f7-4c33-8462-631cf2f629d1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.9,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "The SENZA-PDN study’s exclusion criteria are sweeping and aggressive, illustrating the cherry-picking and absurdity KOL’s pointed out. The criteria bend over backward to exclude bread-and-butter diabetics, such as those with pain anywhere but the lower limbs, severe obesity, recipients of Social Security disability, anyone with a worker’s comp claim, and various restrictions on opioid use or ulcers.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "824dc875-aa86-4e8a-87dd-0250ec35ba77",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.06,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: https://clinicaltrials.gov/ct2/show/NCT03228420",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "41948f88-81fc-4c0a-9623-4116fbbeab0b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.85,
        "x": 0.06,
        "y": 0.09
      },
      "kind": "title",
      "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a0d76d5-3ae9-4c28-b27d-59959a32d48c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bd6ba853-00e2-4994-8d5b-e7d0c1f999c9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.45,
        "x": 0.06,
        "y": 0.28
      },
      "kind": "title",
      "text": "SENZA-PDN exclusion criteria per ClinicalTrials.gov",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c51845e7-f52e-40c9-8a89-150ee9112e15",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "a51e399b-9142-48fd-96ad-4cf61d0ebe07",
      "evidence": "Uses clinical trial data to argue that the company's growth narrative is based on manipulated/cherry-picked data.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}